Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |